Unresectable hepatocellular carcinoma effectively treated with durvalumab and tremelimumab after splenectomy: a case study

Authors

Kenta Motomura (ORCID: https://orcid.org/0000-0002-7515-099X)
Masayoshi Yada (ORCID: https://orcid.org/0000-0002-1129-5380)
Shigehiro Nagasawa
Akifumi Kuwano (ORCID: https://orcid.org/0000-0001-9397-8056)
Masatake Tanaka (ORCID: https://orcid.org/0000-0001-7461-0678)
Yuta Koga
Akihide Masumoto

Institutions

Aso Iizuka Hospital (JP)

Publication Details

Journal: Kanzo
Published: 2024-08-01
DOI: https://doi.org/10.2957/kanzo.65.391
Primary Topic: Hepatocellular Carcinoma Treatment and Prognosis
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Unresectable hepatocellular carcinoma effectively treated with durvalumab and tremelimumab after splenectomy: a case study

Kenta Motomura, Masayoshi Yada, Shigehiro Nagasawa, Akifumi Kuwano et al.

Aug 1, 2024

Kanzo

Hepatocellular Carcinoma Treatment and Prognosis

article

Unresectable hepatocellular carcinoma effectively treated with durvalumab and tremelimumab after splenectomy: a case study

Kenta Motomura, Masayoshi Yada, Shigehiro Nagasawa, Akifumi Kuwano, Masatake Tanaka, Yuta Koga, Akihide Masumoto

August 1, 2024article en

Abstract

No abstract available for this paper.

KanzoVol. 65(8)

Aso Iizuka Hospital (JP)

Zero hunger

Openalex Percentile: Top 79%

Hepatocellular Carcinoma Treatment and Prognosis

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Unresectable hepatocellular carcinoma effectively treated with durvalumab and tremelimumab after splenectomy: a case study — Kenta Motomura, Masayoshi Yada, et al. · Kanzo (2024) | TGRS Research Map | TGRS